Brahmi Extract Regulatory & Compliance Guide (EU, US, India)

European Union: Lead with MRL and Heavy Metals

For EU-bound Brahmi, the first compliance questions are contaminants, not health claims. Pesticide residues must meet the maximum residue levels set under Regulation (EC) 396/2005, and heavy metals must comply with the contaminants framework (Regulation (EC) 1881/2006 and successors). Because bacopa is a semi-aquatic plant that can bioaccumulate metals, a batch-specific ICP-MS heavy-metal report and a current pesticide-residue (MRL) report should be baseline documentation, not an afterthought.

Ethylene Oxide and Increased Official Controls

Indian botanical extracts are subject to increased official controls at the EU border under Regulation (EU) 2019/1793, with ethylene oxide (ETO) a recurring cause of rejections across the herbal-extract category. In practice this means:

• The consignment needs a CHED-D (Common Health Entry Document) lodged in TRACES and must enter through a designated control point.
• Consignments face documentary and a percentage of identity and physical checks, including ETO testing.
• Pre-testing ETO before shipment — and confirming the material was never ETO-sterilised — is the single most effective way to avoid a border rejection.

EU Food-Supplement Status

Bacopa monnieri is used in food supplements in several EU member states under national botanical lists, but botanical rules are not fully harmonised across the EU — permitted use, and any restrictions, are assessed member state by member state. Labelling must comply with Regulation (EU) 1169/2011, and any specific ingredient status (including novel-food considerations for particular preparations) should be confirmed for the exact form and market before launch. Treat this as a per-market legal check, not a blanket assumption.

United States

In the US, bacopa is marketed as a dietary ingredient under DSHEA (21 CFR Part 111), with an established history of use. No pre-market approval is required, but the importer’s facility must be FDA-registered, cGMP applies, and structure–function claims must be substantiated and notified to the FDA. Heavy-metal limits — including California’s Proposition 65 exposure thresholds — make ICP-MS-tested material essential for the US market.

India & Other Markets

In India, Brahmi is a classical Medhya Rasayana recognised under AYUSH, and is relevant to supplement use under the FSS (Health Supplements, Nutraceuticals…) Regulations 2022. It is widely accepted across the Middle East (where Halal grades are typically required) and Southeast Asia, subject to local heavy-metal and labelling limits. Always map the destination market’s contaminant and labelling rules before shipping.

Documentation Checklist

• Batch-specific Certificate of Analysis with bacoside result and method, identity, heavy metals and microbiology.
• Pesticide-residue (MRL) report and ETO statement/test for EU consignments.
• MSDS, allergen and Non-GMO declarations, BSE/TSE-free statement.
• Country of Origin certificate and, where required, Halal or Kosher certification.

For how these requirements shape a purchase specification, see the Brahmi extract buyer’s guide; for the supply-chain side of contaminant control, see the sourcing guide. This overview is general information, not legal advice — confirm current requirements with a qualified regulatory specialist for your market.